🔎 Trials Near Me

Akèy › Kansè vejik › Virginia › Arlington

Etid klinik pou Kansè vejik nan Arlington, VA

8 etid pou Kansè vejik ap chèche patisipan nan sit nan ak bò kote Arlington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Ap rekriteFaz 1/2
  • Virginia Cancer Specialists, PC, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Ap rekriteFaz 1
  • NEXT Oncology Virginia, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07277413

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Ap rekriteFaz 1
  • Virginia Cancer Specialists, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07217171

The Vanguard Study: Testing a New Way to Screen for Cancer

Ap rekriteVolontè an sante akeyi
  • Inova Schar Cancer Institute, Fairfax · 11 mi lwen
  • Inova Fair Oaks Hospital, Fairfax · 11 mi lwen
Laj 45 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06995898

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Ap rekriteFaz 3
  • Research Site, Falls Church · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07720284

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Ap rekriteFaz 2
  • Inova Schar Cancer Institute, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT04879329

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ap rekriteFaz 1
  • Virginia Cancer Specialists, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • NEXT Virginia, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 18, 2026 · NCT07030257

Etid Kansè vejik nan lòt vil

Lòt etid nan Arlington

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.